GNB5 and Alzheimer disease: Given the first WD40 domain of Gnb5 (Gnb5 (28-102aa)) is essential for its binding with BACE1 and the S81L mutation disrupts its role, we wondered whether this protein fragment could attenuate AD pathology in vivo.